Volume 86 Issue 4, 12 February 2002

A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma

• J Dinnes
• C Cave
• R Milne

Review Open Access 12 Feb 2002

Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [¹⁸F]FDG PET

• C Bokemeyer
• C Kollmannsberger
• L Kanz

Clinical Open Access 12 Feb 2002

FDG–PET. A possible prognostic factor in head and neck cancer

• W Halfpenny
• S F Hain
• M McGurk

Clinical Open Access 12 Feb 2002

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation

• H K Awwad
• M Lotayef
• S Eissa

Clinical Open Access 12 Feb 2002

CT-guided intratumoural administration of cisplatin/epinephrine gel for treatment of malignant liver tumours

• T J Vogl
• K Engelmann
• E Orenberg

Clinical Open Access 12 Feb 2002

Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N₂ non-small cell lung cancer

• H Date
• K Kiura
• N Shimizu

Clinical Open Access 12 Feb 2002

Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours

• B C Goh
• E E Vokes
• M J Ratain

Clinical Open Access 12 Feb 2002

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

• G Pérez-Tenorio
• O Stål

Molecular and Cellular Pathology Open Access 12 Feb 2002

Dendritic cell density and activation status in human breast cancer – CD1a, CMRF-44, CMRF-56 and CD-83 expression

• B J Coventry
• P-L Lee
• D N J Hart

Molecular and Cellular Pathology Open Access 12 Feb 2002

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma

• H Shimada
• T Hoshino
• T Ochiai

Molecular and Cellular Pathology Open Access 12 Feb 2002

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma

• G Fontanini
• P Faviana
• R Pingitore

Molecular and Cellular Pathology Open Access 12 Feb 2002

Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability

• K Sakata
• G Tamura
• T Motoyama

Molecular and Cellular Pathology Open Access 12 Feb 2002

c-erbB-2 is not a major factor in the development of colorectal cancer

• J A McKay
• J F Loane
• H L McLeod

Molecular and Cellular Pathology Open Access 12 Feb 2002

Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer

• G Deng
• E Peng
• Y S Kim

Genetics and Genomics Open Access 12 Feb 2002

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

• I Bièche
• M Olivi
• R Lidereau

Genetics and Genomics Open Access 12 Feb 2002

Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas

• N Shinoura
• S Sakurai
• H Hamada

Genetics and Genomics Open Access 12 Feb 2002

Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours

• F Abel
• R-M Sjöberg
• T Martinsson

Genetics and Genomics Open Access 12 Feb 2002

Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity

• J Van heusden
• R Van Ginckel
• W Wouters

Experimental Therapeutics Open Access 12 Feb 2002

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor

• C Bing
• S T Russell
• G Williams

Experimental Therapeutics Open Access 12 Feb 2002

Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells

• M L Turcotte
• M Parliament
• J Allalunis-Turner

Experimental Therapeutics Open Access 12 Feb 2002

A cyclin-dependent kinase inhibitor (p21^WAF1/CIP1) affects thymidine incorporation in human liver cancer cells

• Y Gong
• S Deng
• F Burczynski

Experimental Therapeutics Open Access 12 Feb 2002

Interaction of cimetidine with P450 in a mouse model of hepatocarcinogenesis initiation

• F Caballero
• E Gerez
• E Vazquez

Experimental Therapeutics Open Access 12 Feb 2002

Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y₂-receptors

• K Maaser
• M Höpfner
• H Scherübl

Experimental Therapeutics Open Access 12 Feb 2002

Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1

• S Tian
• A J Hayes
• L-Y Li

Experimental Therapeutics Open Access 12 Feb 2002

Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy

• L Prasmickaite
• A Høgset
• K Berg

Experimental Therapeutics Open Access 12 Feb 2002

Endothelial hyperplasia: an important indicator of actual angiogenesis

• J T Beranek

Letter to the Editor Open Access 12 Feb 2002

^99mTc-labelled Stealth^® liposomal doxorubicin (Caelyx^®) in glioblastomas and metastatic brain tumours

• P Laverman
• O C Boerman
• W J G Oyen

Letter to the Editor Open Access 12 Feb 2002

Reply: ^99mTc-labelled Stealth liposomal doxorubicin (Caelyx^®) in glioblastomas and metastatic brain tumours

• M I Koukourakis

Letter to the Editor Open Access 12 Feb 2002

Principles and practice of the biologic therapy of cancer (third edition)

• R T D Oliver

Book Review Open Access 12 Feb 2002